Maryland Careers

No results for "${pageStateData.searchKeyword}"

No results for "${pageStateData.placeVal}"

Would you like to consider the job categories below?

Harmans (BWI)

The Harmans/BWI-1 EMA and FDA approved facility, at approximately 200,000 sq. ft., houses 10 CGMP manufacturing suites, fill/finish, central services, testing labs, and a warehouse.

The Harmans/BWI-2 facility, at approximately 145,000 sq. ft., is under development and will house 8 CGMP manufacturing suites and cold storage warehousing.

Both facilities support Phase 3 through commercial manufacturing of advanced therapeutic products including AAV and other viral vector-based therapies and vaccines.

Our Gene Therapy facility, located at the University of Maryland (UMD) BioPark in Baltimore, MD, specializes in upstream and downstream process development of viral vectors for clinical applications. 

The facility houses process development labs and CGMP cleanroom suites for Phase 1 and 2 programs focused on traditional AAV and other viral vector-based programs